Anand has close to 20 years experience in the life sciences industry across medtech, biotech and pharma.
After completing his PhD in Bone tissue engineering, he worked for a medtech start-up leading the development of novel polymer based scaffolds for cardiovascular applications, culminating in a FIH study in young children.
After that, Anand spent time in an MNC focusing on vaccine development and later at a scale-up leading the operational readiness of the company’s 1st CAR-T cell therapy facility in the Netherlands.
Anand combines his scientific and technical knowledge with strong program alliance management skills to further innovation and help patients in need.
